Shedding new light on a devastating disease
More than 5 million Americans are living with Alzheimer’s disease, with a new case diagnosed every 66 seconds. Researchers at the Philip Haydon Lab at the Tufts University School of Medicine are working tirelessly to understand and treat this neurodegenerative condition that robs patients of memories, and eventually their lives.
Groundbreaking research on glial cells—cells that are electrically silent and previously thought to be passive—is now being conducted into their pivotal roles in the control of brain behavior. This insight offers a new and potentially revolutionary treatment approach, which works by recruiting glial cells to remove Alzheimer’s telltale amyloid plaques.
For Alzheimer’s patients and their families, time is precious. By supporting this innovative research, you help us bring hope and longer life to millions. Make a gift today.
- medicine-giving@tufts.edu
- 617-636-6770